EPITERNA develops affordable products that can safely slow the ageing process to prevent age-related disease, delay functional decline, and extend life.
Epiterna has raised €10M across 1 funding round from 1 investor, most recently a round in Aug 2023. Based in Epalinges, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-08-01 | Other | €10M |
| Prima Materia |
| View deal → |
